CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company …
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for NASDAQ skewed neutral (213 of 478 scored calls). The most accurate provider on this asset is groq-llama-3.1-8b-instant at 41.0% across 444 verified calls.
AI-curated news influencing NASDAQ price, sentiment, and trend
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company …
Whether you're a day trader back home visiting family, or just locked into what remains of the trading week here, …
Tuesday's flurry of delayed data releases could fill in gaps in Wall Street's picture of the economy.
The S&P 500 is on track for its highest close on record. The market benchmark was up 0.4% to 6905, …
US equity indexes rose in midday trading on Tuesday amid mixed macroeconomic data. The Nasdaq Com
Stock Market Today: The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval …
Multi-Provider AI Analysis